Case and Research Letter
Malignant Spiradenoma: a Giant Cutaneous Adnexal Tumor
Espiradenoma maligno: un tumor gigante de los anexos cutáneos
Leído
6712
Vecesse ha leído el artículo
2050
Total PDF
4662
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 55 | 0 | 55 |
| 2025 5 | 243 | 39 | 282 |
| 2025 4 | 220 | 24 | 244 |
| 2025 3 | 183 | 18 | 201 |
| 2025 2 | 213 | 34 | 247 |
| 2025 1 | 150 | 41 | 191 |
| 2024 12 | 133 | 35 | 168 |
| 2024 11 | 122 | 58 | 180 |
| 2024 10 | 79 | 39 | 118 |
| 2024 9 | 114 | 25 | 139 |
| 2024 8 | 128 | 51 | 179 |
| 2024 7 | 127 | 37 | 164 |
| 2024 6 | 122 | 56 | 178 |
| 2024 5 | 98 | 30 | 128 |
| 2024 4 | 92 | 33 | 125 |
| 2024 3 | 80 | 26 | 106 |
| 2024 2 | 65 | 31 | 96 |
| 2024 1 | 64 | 29 | 93 |
| 2023 12 | 77 | 14 | 91 |
| 2023 11 | 72 | 28 | 100 |
| 2023 10 | 66 | 18 | 84 |
| 2023 9 | 80 | 33 | 113 |
| 2023 8 | 60 | 13 | 73 |
| 2023 7 | 97 | 38 | 135 |
| 2023 6 | 64 | 24 | 88 |
| 2023 5 | 54 | 22 | 76 |
| 2023 4 | 58 | 27 | 85 |
| 2023 3 | 57 | 27 | 84 |
| 2023 2 | 58 | 17 | 75 |
| 2022 1 | 36 | 25 | 61 |
| 2022 12 | 53 | 36 | 89 |
| 2022 11 | 45 | 41 | 86 |
| 2022 10 | 31 | 35 | 66 |
| 2022 9 | 26 | 37 | 63 |
| 2022 8 | 24 | 35 | 59 |
| 2022 7 | 25 | 25 | 50 |
| 2022 6 | 16 | 27 | 43 |
| 2022 5 | 32 | 35 | 67 |
| 2022 4 | 48 | 26 | 74 |
| 2022 3 | 43 | 36 | 79 |
| 2022 2 | 35 | 29 | 64 |
| 2021 1 | 28 | 33 | 61 |
| 2021 12 | 28 | 37 | 65 |
| 2021 11 | 36 | 35 | 71 |
| 2021 10 | 43 | 45 | 88 |
| 2021 9 | 28 | 39 | 67 |
| 2021 8 | 32 | 22 | 54 |
| 2021 7 | 28 | 18 | 46 |
| 2021 6 | 25 | 25 | 50 |
| 2021 5 | 37 | 25 | 62 |
| 2021 4 | 72 | 37 | 109 |
| 2021 3 | 48 | 21 | 69 |
| 2021 2 | 47 | 28 | 75 |
| 2020 1 | 31 | 12 | 43 |
| 2020 12 | 16 | 18 | 34 |
| 2020 11 | 33 | 27 | 60 |
| 2020 10 | 14 | 14 | 28 |
| 2020 9 | 31 | 6 | 37 |
| 2020 8 | 21 | 13 | 34 |
| 2020 7 | 12 | 15 | 27 |
| 2020 6 | 38 | 28 | 66 |
| 2020 5 | 24 | 23 | 47 |
| 2020 4 | 27 | 19 | 46 |
| 2020 3 | 32 | 13 | 45 |
| 2020 2 | 9 | 4 | 13 |
| 2019 12 | 0 | 3 | 3 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 1 | 0 | 1 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 4 | 4 |
| 2019 5 | 3 | 25 | 28 |
| 2019 4 | 1 | 2 | 3 |
| 2019 3 | 0 | 3 | 3 |
| 2019 1 | 2 | 0 | 2 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 1 | 0 | 1 |
| 2018 8 | 0 | 5 | 5 |
| 2018 7 | 0 | 7 | 7 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 1 | 1 |
| 2018 2 | 12 | 2 | 14 |
| 2018 1 | 33 | 4 | 37 |
| 2017 12 | 27 | 6 | 33 |
| 2017 11 | 35 | 3 | 38 |
| 2017 10 | 29 | 7 | 36 |
| 2017 9 | 22 | 6 | 28 |
| 2017 8 | 37 | 4 | 41 |
| 2017 7 | 23 | 7 | 30 |
| 2017 6 | 33 | 13 | 46 |
| 2017 5 | 41 | 13 | 54 |
| 2017 4 | 24 | 8 | 32 |
| 2017 3 | 18 | 41 | 59 |
| 2017 2 | 25 | 9 | 34 |
| 2016 1 | 17 | 12 | 29 |
| 2016 12 | 26 | 21 | 47 |
| 2016 11 | 37 | 16 | 53 |
| 2016 10 | 23 | 11 | 34 |
| 2016 8 | 1 | 1 | 2 |
| 2016 6 | 0 | 1 | 1 |
Mostrar todo
